SCHEMBL7898579

SCHEMBL7898579

CCOc1cc(CC(=O)NC(CC(C)C)c2ccccc2N2CCCCC2)ccc1CCl

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.77
ABCC8 Q09428 3/20 0.77
LMNA P02545 3/20 0.77
MAPK1 P28482 2/20 0.77
SLC22A1 O15245 1/20 0.77
ABCC3 O15438 1/20 0.77
ABCC4 O15439 1/20 0.77
NR1I2 O75469 1/20 0.77
ABCB11 O95342 1/20 0.77
ADORA3 P0DMS8 1/20 0.77
HTR2A P28223 1/20 0.77
ADRA1A P35348 1/20 0.77
PTGS2 P35354 1/20 0.77
PDE4D Q08499 1/20 0.77
NR1I3 Q14994 1/20 0.77
ABCC2 Q92887 1/20 0.77
NR1H4 Q96RI1 1/20 0.77
GAA P10253 3/20 0.44
GFER P55789 1/20 0.44
MC4R P32245 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7900185 0.91 ABCC8 (0.64) CYP3A4ABCC8LMNAMAPK1SLC22A1
SCHEMBL7895996 0.89 CYP3A4 (0.73) CYP3A4ABCC8LMNAMAPK1SLC22A1
Repaglinide SCHEMBL29373506 0.87 ABCC8 (1.00) CYP3A4ABCC8LMNAMAPK1SLC22A1
Repaglinide SCHEMBL29598841 0.87 ABCC8 (1.00) CYP3A4ABCC8LMNAMAPK1SLC22A1
SCHEMBL10013499 0.87 ABCC8 (0.87) CYP3A4ABCC8LMNAMAPK1SLC22A1
Repaglinide SCHEMBL163867 0.87 ABCC8 (1.00) CYP3A4ABCC8LMNAMAPK1SLC22A1
Repaglinide SCHEMBL1536902 0.87 ABCC8 (1.00) CYP3A4ABCC8LMNAMAPK1SLC22A1
SCHEMBL3008216 0.87 LMNA (0.87) CYP3A4ABCC8LMNAMAPK1SLC22A1
Repaglinide SCHEMBL8141950 0.87 ABCC8 (1.00) CYP3A4ABCC8LMNAMAPK1SLC22A1
Repaglinide SCHEMBL29392295 0.87 ABCC8 (1.00) CYP3A4ABCC8LMNAMAPK1SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE37035-E1 HYPOGLYCEMIC AGENTS BOEHRINGER INGELHEIM KG (DE) 2001-01-30 US disclosed
US-6143769-A ENANTIOMORPH KARL THOMAE GMBH (DE) 2000-11-07 US disclosed
US-5312924-A Compounds for lowering blood sugar and effecting metabolism DR. KARL THOMAE GMBH (DE) 1994-05-17 US disclosed
US-5216167-A Hypoglycemic agents DR. KARL THOMAE GMBH (DE) 1993-06-01 US disclosed
EP-0208200-A1 Phenylacetic-acid derivatives, pharmaceutical compositions containing them and processes for their production Dr. Karl Thomae GmbH (DE) 1987-01-14 EP disclosed